Solar Energy News  
EPIDEMICS
Surge for kids' vaccines in Hong Kong after China scandal
by Staff Writers
Hong Kong (AFP) July 24, 2018

15 detained in China vaccine scandal
Beijing (AFP) July 25, 2018 - Chinese authorities have arrested 15 people including the chairwoman of a rabies vaccine producer under fire for fraudulent quality control in the country's latest drug-safety scandal.

News that pharmaceutical manufacturer Changchun Changsheng Biotechnology had fabricated records and was ordered to cease production of rabies vaccines has revived deep consumer unease over product safety in the country, fuelled by recurring scandals over the years.

Authorities in the northeastern city of Changchun, where the company is based, have arrested 15 people including the company's chairwoman on "suspicion of criminal offences", city police announced late on Tuesday.

The announcement did not give the chairwoman's full name but she has previously been identified as Gao Junfang.

The affair has shattered already fragile trust in regulators and spotlighted the frustrations of China's increasingly sophisticated consumers, who took to social media en masse to vent their anger over the case.

The China Food and Drug Administration (CFDA) said last week the problematic rabies vaccine had not left Changsheng's factory, but the company admitted it had shipped a separate sub-standard vaccine.

That vaccine for diphtheria, whooping cough and tetanus was found by regulators to fail quality standards, but the company revealed that it sold 250,000 doses to Shandong province last year.

The problems have rekindled already deep fears over domestically made medicines and driven worried parents online to swap information on obtaining imported vaccines.

Authorities have announced a series of investigations and vowed that heads would roll.

In a sign of the high-level unease, President Xi Jinping -- on a trip to Africa -- weighed in on Monday, calling the vaccine company's actions "vile in nature and shocking", according to state media.

Hong Kong clinics said they have seen a surge in demand for children's vaccines Tuesday after a safety scandal rocked mainland China.

The crisis stemmed from falsified production data of a rabies inoculation by a major mainland manufacturer.

But vaccines against diphtheria, tetanus and whooping cough, given to babies and infants, were also found to be sub-standard, with doses already sold and administered.

The mounting scandal has raised questions about the safety of China's entire vaccine industry and has led some parents to seek treatment in semi-autonomous Hong Kong.

The city already has a reputation for safer medication than mainland China and has seen a rush on its products in the past after health scandals over the border.

One private Hong Kong clinic in the commercial hub of Tsim Sha Tsui said it had received hundreds of calls and messages, around six times the normal rate of enquiries, since the scandal broke over the weekend.

Manager Jacky Ho described the demand as "explosive", saying it was mostly from mainland Chinese parents looking for vaccines imported from countries other than China.

"The closest place for them to get the vaccines is Hong Kong," said Ho, who added the clinic's inoculations come from England, France and the United States.

A woman who gave her name as Mrs Yin, from Shenzhen in southern mainland China, said she had brought her two-year-old son to the clinic for three different types of vaccinations.

"We are worried about the quality of domestic vaccines," said Yin, who said she had spent HK$5,000 ($640) on the inoculations: PCV13 which protects against pneumococcal bacteria, Japanese encephalitis and the ACWY vaccination to protect against meningitis.

She said she had made an appointment for the PCV13 jab before the crisis broke, but had added the other inoculations for good measure after hearing of the scandal.

Another man from Guangdong in southern China, who gave his surname Chan said he had brought his one-year-old son to a private clinic in the same area for the PCV13 inoculation after making an appointment two months ago.

"Now I feel very lucky that we came here. We have more confidence in Hong Kong," he told AFP.

Private hospital Hong Kong Sanatorium said it had seen a rise in enquiries and had contacted suppliers to ensure "a stable supply of vaccines to meet the needs of patients in coming days" in a statement to AFP.

Hong Kong's health department said it would closely monitor the supply of vaccines to both public and private healthcare sectors but described it as "stable" for now.

Scarlett Pong, president of the city's Pharmaceutical Society, added that there was an established information network which connected Hong Kong clinics with mainland Chinese customers.

"There are agents helping them make appointments and who know where to get information like which doctor to use," she told AFP.

yz-ey-ec-lm/jta


Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


EPIDEMICS
Chinese president calls latest pharma scare "vile"
Shanghai (AFP) July 23, 2018
Chinese President Xi Jinping on Monday described a vaccine safety scandal as "vile" and "shocking" as police opened a criminal investigation into the firm responsible and its management. Xi, on a trip to Africa, echoed the calls from Premier Li Keqiang for a thorough investigation and stern action over the latest safety scare to hit the pharmaceutical industry. "Changchun Changsheng Biotechnology's illegal production of vaccines is vile in nature and shocking," Xi said, according to state broadc ... read more

Comment using your Disqus, Facebook, Google or Twitter login.



Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

EPIDEMICS
Feeding plants to this algae could fuel your car

Splitting water: Nanoscale imaging yields key insights

Carbon dioxide-to-methanol process improved by catalyst

Finding the right balance for catalysts in the hydrogen evolution reaction

EPIDEMICS
Emotional robot lets you feel how it's 'feeling'

Army researchers teaching robots to be more reliable teammates for soldiers

New creepy, crawly search and rescue robot developed at Ben-Gurion

In China, yellow robots deliver snacks to your home

EPIDEMICS
Searching for wind for the future

Clock starts for Germany's next wind farm

ENGIE: Wind energy footprint firmed up in Norway

Batteries make offshore wind energy debut

EPIDEMICS
EU says VW repairs most cars with cheating devices

Elon Musk's latest outburst raises doubts on leadership

Washington state sets high bar for electric vehicles

Departing Apple engineer stole autonomous car tech: FBI

EPIDEMICS
New battery could store wind and solar electricity affordably and at room temperature

Researchers upend conventional wisdom on thermal conductivity

High-power thermoelectric generator utilizes thermal difference of only 5C

Chemical engineers pack more energy in same space for reliable battery

EPIDEMICS
SUSI submarine robot enables successful visual Inspection at Asco Nuclear Power Plant

Manufacturing operations are ramping up at Framatome Le Creusot site

GE Hitachi Selected by U.S. Department of Energy to Lead Advanced Nuclear Technology Development Project

Fukushima nuclear plant operator resumes TV ads

EPIDEMICS
Global quadrupling of cooling appliances to 14 billion by 2050

Equinor buys short-term electricity trader

China reviewing low-carbon efforts

Path to zero emissions starts out easy, but gets steep

EPIDEMICS
In Mozambique, a joint fight against climate change and forest loss

Ancient farmers transformed Amazon and left an enduring legacy on the rainforest

Study shows 5,000 percent increase in native trees on rat-free Palmyra Atoll

Brazil's Forest Code can balance the needs of agriculture and the environment









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.